{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:23:11Z","timestamp":1790644991523,"version":"4.1.0"},"reference-count":73,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2021,1,19]]},"abstract":"<jats:p>Background: Cognitively normal (CN) older adults participating in Alzheimer\u2019s disease (AD) research increasingly ask for their research results\u2014including genetic and neuroimaging findings\u2014to understand their risk of developing AD dementia. AD research results are typically not returned for multiple reasons, including possible psychosocial harms of knowing one is at risk of a highly feared and untreatable disease. Objective: We developed materials that convey information about 5-year absolute risk of developing AD dementia based on research results. Methods: 20 CN older adults who received a research brain MRI result were interviewed regarding their wishes for research results to inform material development (Pilot 1). Following material development, 17 CN older adults evaluated the materials for clarity and acceptability (Pilot 2). All participants were community-dwelling older adults participating in longitudinal studies of aging at a single site. Results: Participants want information on their risk of developing AD dementia to better understand their own health, satisfy curiosity, inform family, and future planning. Some articulated concerns, but the majority wanted to know their risk despite the limitations of information. Participants found the educational materials and results report clear and acceptable, and the majority would want to know their research results after reviewing them. Conclusion: These materials will be used in a clinical study examining the psychosocial and cognitive effects of offering research results to a cohort of CN older adults. Future AD research may incorporate the return of complex risk information to CN older adults, and materials are needed to communicate this information.<\/jats:p>","DOI":"10.3233\/jad-200993","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T12:43:15Z","timestamp":1608036195000},"page":"559-572","source":"Crossref","is-referenced-by-count":21,"title":["Communicating 5-Year Risk of Alzheimer\u2019s Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results"],"prefix":"10.1177","volume":"79","author":[{"given":"Jessica","family":"Mozersky","sequence":"first","affiliation":[{"name":"Bioethics Research Center, Division of General Medical Sciences, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hartz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Linnenbringer","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillie","family":"Levin","sequence":"additional","affiliation":[{"name":"Bioethics Research Center, Division of General Medical Sciences, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Streitz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St. Louis, MO; and Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Stock","sequence":"additional","affiliation":[{"name":"Washington University Danforth College of Arts and Sciences (post-baccalaureate program) and Music Speaks, LLC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Moulder","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St. Louis, MO; and Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St. Louis, MO; and Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-200993_ref1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.46.1.142","article-title":"The consortium to establish a registry for Alzheimer\u2019s Disease (CERAD). Part XIII. Obtaining autopsy in Alzheimer\u2019s disease","volume":"46","author":"Fillenbaum","year":"1996","journal-title":"Neurology"},{"key":"10.3233\/JAD-200993_ref2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200993_ref3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-200993_ref4","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.3233\/JAD-200993_ref5","doi-asserted-by":"crossref","first-page":"102248","DOI":"10.1016\/j.nicl.2020.102248","article-title":"Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia","volume":"26","author":"Koenig","year":"2020","journal-title":"Neuroimage Clin"},{"key":"10.3233\/JAD-200993_ref6","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"10.3233\/JAD-200993_ref7","doi-asserted-by":"crossref","first-page":"e20200861","DOI":"10.1084\/jem.20200861","article-title":"Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease","volume":"217","author":"Barth\u00e9lemy","year":"2020","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-200993_ref8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"10.3233\/JAD-200993_ref9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrneurol.2012.241","article-title":"Preclinical Alzheimer disease-the challenges ahead","volume":"9","author":"Sperling","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-200993_ref10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-200993_ref11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3389\/fnhum.2014.00921","article-title":"Before it is too late: Professional responsibilities in late-onset Alzheimer\u2019s research and pre-symptomatic prediction","volume":"8","author":"Schicktanz","year":"2014","journal-title":"Front Hum Neurosci"},{"key":"10.3233\/JAD-200993_ref12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jalz.2016.01.009","article-title":"Ethical challenges in preclinical Alzheimer\u2019s disease observational studies and trials: Results of the Barcelona summit","volume":"12","author":"Molinuevo","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200993_ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WAD.0000000000000016","article-title":"Facilitating Alzheimer disease research recruitment","volume":"28","author":"Grill","year":"2014","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-200993_ref16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neurobiolaging.2015.11.007","article-title":"Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer\u2019s disease clinical trials","volume":"39","author":"Grill","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-200993_ref17","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/jamaneurol.2015.2875","article-title":"Attitudes of research participants and the general public regarding disclosure of Alzheimer disease research results","volume":"72","author":"Gooblar","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-200993_ref18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.trci.2015.12.001","article-title":"A survey of knowledge and views concerning genetic and amyloid PET status disclosure","volume":"2","author":"Ott","year":"2016","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-200993_ref19","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.mayocp.2014.05.016","article-title":"Public perceptions of presymptomatic testing for Alzheimer disease","volume":"89","author":"Caselli","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.3233\/JAD-200993_ref20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/alzrt206","article-title":"Would you want to know? Public attitudes on early diagnostic testing for Alzheimer\u2019s disease","volume":"5","author":"Wikler","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-200993_ref21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jalz.2012.03.001","article-title":"Risk disclosure and preclinical Alzheimer\u2019s disease clinical trial enrollment","volume":"9","author":"Grill","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200993_ref22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","article-title":"The personal and clinical utility of polygenic risk scores","volume":"19","author":"Torkamani","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.3233\/JAD-200993_ref23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200993_ref24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200993_ref25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2967\/jnumed.113.120618","article-title":"Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer\u2019s Association","volume":"54","author":"Johnson","year":"2013","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-200993_ref26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.0b013e318232ac1a","article-title":"Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease","volume":"77","author":"Karlawish","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-200993_ref28","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1212\/WNL.0000000000001451","article-title":"Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-200993_ref29","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3233\/JAD-180638","article-title":"Ethical arguments concerning the use of Alzheimer\u2019s disease biomarkers in individuals with no or mild cognitive impairment: A systematic review and framework for discussion","volume":"66","author":"Smedinga","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200993_ref30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.dadm.2018.02.006","article-title":"Advances in Alzheimer\u2019s imaging are changing the experience of Alzheimer\u2019s disease","volume":"10","author":"Stites","year":"2018","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-200993_ref31","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1017\/S1041610215000848","article-title":"A review of ethical issues in dementia","volume":"27","author":"Johnson","year":"2015","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-200993_ref32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jama.2018.7898","article-title":"Return of research results to study participants: Uncharted and untested","volume":"320","author":"Wong","year":"2018","journal-title":"JAMA"},{"key":"10.3233\/JAD-200993_ref33","doi-asserted-by":"crossref","first-page":"228fs213","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: Stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-200993_ref34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-200993_ref36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pneurobio.2013.08.003","article-title":"A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases","volume":"110","author":"Paulsen","year":"2013","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-200993_ref37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13195-018-0398-3","article-title":"Disclosure of amyloid positron emission tomography results to individuals without dementia: A systematic review","volume":"10","author":"de Wilde","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-200993_ref38","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jalz.2015.09.005","article-title":"Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability","volume":"12","author":"Lim","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200993_ref39","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jalz.2017.01.022","article-title":"Safety of disclosing amyloid status in cognitively normal older adults","volume":"13","author":"Burns","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200993_ref40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0809578","article-title":"Disclosure of APOE genotype for risk of Alzheimer\u2019s disease","volume":"361","author":"Green","year":"2009","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-200993_ref41","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jalz.2014.10.014","article-title":"A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer\u2019s disease","volume":"11","author":"Green","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200993_ref42","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.2734"},{"key":"10.3233\/JAD-200993_ref43","doi-asserted-by":"crossref","first-page":"e0229137","DOI":"10.1371\/journal.pone.0229137","article-title":"Cognitively unimpaired adults\u2019 reactions to disclosure of amyloid PET scan results","volume":"15","author":"Largent","year":"2020","journal-title":"PLoS One"},{"key":"10.3233\/JAD-200993_ref45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamaneurol.2017.2954","article-title":"Comprehension of an elevated amyloid positron emission tomography biomarker result by cognitively normal older adults","volume":"75","author":"Mozersky","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-200993_ref46","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/jnci\/djr318","article-title":"Helping patients decide: Ten steps to better risk communication","volume":"103","author":"Fagerlin","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.3233\/JAD-200993_ref47","unstructured":"Mozersky J , Hartz S (2020) Returning Research Results That Indicate Risk Of Alzheimer Disease To Healthy Participants In Longitudinal Studies. National Institute of Aging."},{"key":"10.3233\/JAD-200993_ref48","first-page":"1","volume-title":"The Coding Manual for Qualitative Researchers","author":"Salda\u00f1a","year":"2016"},{"key":"10.3233\/JAD-200993_ref49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-015-0112-7","article-title":"Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants","volume":"7","author":"Harkins","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-200993_ref50","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.trci.2019.09.013","article-title":"Alzheimer\u2019s Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials","volume":"5","author":"Langlois","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-200993_ref52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-150985","article-title":"Development of a standardized approach to disclosing amyloid imaging research results in mild cognitive impairment","volume":"52","author":"Lingler","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200993_ref53","first-page":"463","article-title":"Health literacy: The gap between physicians and patients","volume":"72","author":"Safeer","year":"2005","journal-title":"Am Fam Physician"},{"key":"10.3233\/JAD-200993_ref54","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s11606-012-2046-0","article-title":"Readability of patient education materials available at the point of care","volume":"27","author":"Stossel","year":"2012","journal-title":"J Gen Intern Med"},{"key":"10.3233\/JAD-200993_ref56","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jalz.2015.12.007","article-title":"Inequalities in dementia incidence between six racial and ethnic groups over 14 years","volume":"12","author":"Mayeda","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200993_ref57","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/1533317513488922","article-title":"Incentives and barriers to research participation and brain donation among African Americans","volume":"28","author":"Schnieders","year":"2013","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"Suppl","key":"10.3233\/JAD-200993_ref58","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/WAD.0b013e3181f14a14","article-title":"Barriers and facilitators of African American participation in Alzheimer disease biomarker research","volume":"24","author":"Williams","year":"2010","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-200993_ref59","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/medethics-2013-101887","article-title":"Personal utility in genomic testing: Is there such a thing?","volume":"41","author":"Bunnik","year":"2015","journal-title":"J Med Ethics"},{"key":"10.3233\/JAD-200993_ref60","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/medethics-2018-104772","article-title":"On the personal utility of Alzheimer\u2019s disease-related biomarker testing in the research context","volume":"44","author":"Bunnik","year":"2018","journal-title":"J Med Ethics"},{"key":"10.3233\/JAD-200993_ref61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/15265160600934772","article-title":"Disclosing individual genetic results to research participants","volume":"6","author":"Ravitsky","year":"2006","journal-title":"Am J Bioeth"},{"key":"10.3233\/JAD-200993_ref62","doi-asserted-by":"crossref","first-page":"38cm20","DOI":"10.1126\/scitranslmed.3000952","article-title":"Offering individual genetic research results: Context matters","volume":"2","author":"Beskow","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-200993_ref63","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1399-0004.2008.00988.x","article-title":"Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation","volume":"73","author":"Metcalfe","year":"2008","journal-title":"Clin Genet"},{"key":"10.3233\/JAD-200993_ref64","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cge.12868","article-title":"Sociodemographic, psychosocial and clinical factors associated with uptake of genetic counselling for hereditary cancer: A systematic review","volume":"92","author":"Willis","year":"2017","journal-title":"Clin Genet"},{"key":"10.3233\/JAD-200993_ref65","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.2105\/AJPH.2013.301706","article-title":"A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders","volume":"104","author":"George","year":"2014","journal-title":"Am J Public Health"},{"key":"10.3233\/JAD-200993_ref66","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jamaneurol.2020.1614","article-title":"Addressing health disparities among minority populations: Why clinical trial recruitment is not enough","volume":"77","author":"Wilkins","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-200993_ref67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.trci.2016.09.004","article-title":"African Americans are less likely to enroll in preclinical Alzheimer\u2019s disease clinical trials","volume":"3","author":"Zhou","year":"2016","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-200993_ref68","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/cts.12285","article-title":"Culturally competent strategies for recruitment and retention of African American populations into clinical trials","volume":"8","author":"Otado","year":"2015","journal-title":"Clin Transl Sci"},{"key":"10.3233\/JAD-200993_ref69","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.trci.2019.09.018","article-title":"Recruitment and retention of underrepresented populations in Alzheimer\u2019s disease research: A systematic review","volume":"5","author":"Gilmore-Bykovskyi","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-200993_ref70","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/ajmg.a.35914","article-title":"Attitudes of African Americans toward return of results from exome and whole genome sequencing","volume":"161A","author":"Yu","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.3233\/JAD-200993_ref71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1055-9965.361.13.3","article-title":"The association between race and attitudes about predictive genetic testing","volume":"13","author":"Peters","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.3233\/JAD-200993_ref72","doi-asserted-by":"crossref","first-page":"348ra396","DOI":"10.1126\/scitranslmed.aaf6667","article-title":"Imaging synaptic density in the living human brain","volume":"8","author":"Finnema","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-200993_ref73","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.neuroimage.2014.06.064","article-title":"Quantifying white matter tract diffusion parameters in the presence of increased extra-fiber cellularity and vasogenic edema","volume":"101","author":"Chiang","year":"2014","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-200993_ref74","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/nbm.3129","article-title":"Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice","volume":"27","author":"Wang","year":"2014","journal-title":"NMR Biomed"},{"key":"10.3233\/JAD-200993_ref75","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuroimage.2016.12.026","article-title":"In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging","volume":"148","author":"Zhao","year":"2017","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-200993_ref76","doi-asserted-by":"crossref","first-page":"17757","DOI":"10.1073\/pnas.1010459107","article-title":"Regional aerobic glycolysis in the human brain","volume":"107","author":"Vaishnavi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-200993_ref77","doi-asserted-by":"crossref","first-page":"17763","DOI":"10.1073\/pnas.1010461107","article-title":"Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition","volume":"107","author":"Vlassenko","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-200993_ref78","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cmet.2017.07.010","article-title":"Loss of brain aerobic glycolysis in normal human aging","volume":"26","author":"Goyal","year":"2017","journal-title":"Cell Metab"},{"key":"10.3233\/JAD-200993_ref79","unstructured":"Ryan CL , Bauman K (2016) Educational Attainment in the United States: 2015, in Population Characteristics. National Census Bureau, pp. 20\u2013578."},{"key":"10.3233\/JAD-200993_ref81","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10897-016-0014-2","article-title":"Ancestry testing and the practice of genetic counseling","volume":"26","author":"Kirkpatrick","year":"2017","journal-title":"J Genet Couns"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-200993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:38Z","timestamp":1777370678000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-200993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":73,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-200993","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]}}}